Biocompatibility Innovation

Learn about nascent BCI technology at PCR #LondonValve November 24-26. A cross-disciplinary three-day program focused on transcatheter therapies for valvular heart disease, representing a unique opportunity to share and advance patient care in each fast-moving field of the Heart Team. Two outstanding members of #BCI's Clinical Advisory Board will present their latest research. Professor Isaac George M.D., FACC, FACS will present a #poster on a new technology for the third generation of #polymer heart valves. We hope you join us for Professor Bruno Melica's presentation on BCI's treatment aimed at overcoming the constraints of #glutaraldehyde during the afternoon session of the #program on Sunday, November 24th. BCI would like to recognize and thank Professors #IsaacGeorge and #BrunoMelica for their contributions and for advancing new solutions for prosthetic heart valves. #BiocompatibilityInnovation #PCRLV #LifeSciences #MedTech #Biocompatibility

BCI announces its #Ecosystem Membership with Bio4Dreams, an incubator of innovative startups in #LifeSciences. By joining #Bio4Dreams, #BCI will have access to dedicated services and a wide ranging, qualified #network of partners that work to support the most innovative Italian #startups in the field of #biomedical research. We are honored to join such a comprehensive #network alongside other major players in #Medtech. #Bio4DreamsNetwork #LifeSciences #MedTech #Biocompatibility

Great opportunity for BCI in San Francisco to be embedded in the Silicon Valley network and also to know great Italian enterpreneurs and great Italian companies with very valuable and high science projects!

#BioCompatibilityInnovation thanks INNOVIT - Italian Innovation and Culture Hub for paving its way to #SiliconValley. Last week our CEO, Alessandro Gandaglia was in San Francisco for the #Call4innovit program, an immersive experience and a valuable #opportunity to #network with leading experts as well as to strengthen Silicon Valley's innovation #stakeholder relationships. #biocompatibility #BCIproject #BCItechnology #LifeScience #digitalHealth

We are pleased to announce that #BiocompatibilityInnovation will participate in #NYVALVES2024, The Structural Heart Summit (NYC - June 5th to 7th, 2024). On Friday morning, #June7th, Dr. Isaac George M.D., FACC, FACS will give the #lecture "A Cutting-Edge Polyphenol-Based Coating Technology for the Third Generation of Polymer Heart Valves" presenting and supporting #BCItechnology. Join us at the #Summit: https://lnkd.in/eYJYMnig #biocompatibility #heartvalve #BCIproject

We are very pleased to announce that Shuki Porath has joined the BCI family as a member of our Board of Directors, and our #StrategicBoard. With over 26 years of experience in the #MedTech industry, Shuki has a proven track record in top #management positions.   We asked Mr. #Porath what excites him about the #BCIproject and what he expects in this undertaking. He responded: “I have dedicated most of my career to the #medical #device industry, seeking opportunities to make a difference in peoples’ lives. The #technology developed and the work being done by BCI has the potential to significantly enhance the quality of life for a vast number of patients, by augmenting the #biocompatible performance of every #implantable medical device. It is inspiring to be a part of something so meaningful that can #positively impact our world."   We are eager to have him on #board and believe he will make a valuable contribution to our company as we embark on this #BCIjourney together. Find out more: https://lnkd.in/dPaf_UVk #BioCompatibilityInnovation #BCIteam #BCItechnology #tissuetreatment #medicaldevice #qualityoflife

#BioCompatibilityInnovation is excited to announce that we've been selected as one of the most promising Italian innovative entrepreneurial ventures to take part in #Call4INNOVIT, the tailored #acceleration program offered by INNOVIT - Italian Innovation and Culture Hub. #INNOVIT is the first Italian Innovation and Culture Hub in San Francisco, promoted by the Ministero degli Affari Esteri e della Cooperazione Internazionale, in collaboration with the #Embassy of #Italy in #Washington and the General #Consulate in #SanFrancisco, and managed with the support of the ITA - Italian Trade Agency and the Istituto Italiano di Cultura San Francisco. Thanks to INNOVIT - Italian Innovation and Culture Hub for this exciting opportunity to propel our #growth and engage with Silicon Valley's innovation stakeholders. #biocompatibility #BCIproject #BCItechnology #LifeScience #digitalHealth

A relevant scientific #study by BCI - Filippo Naso, Alessandro Gandaglia, Robert Melder et al. - was published a few days ago on Frontiers in Bioscience-Landmark, which further validates the principle underlying BCI #technology for #implantable biological tissues. The #experiment carried out in vivo demonstrates the ability of the #Facta technology to neutralize the adverse immune reaction towards #alphaGal, which is one of the main agents responsible for triggering the degeneration of biological tissues leading to #calcification, thus creating optimal conditions of #biocompatibility for #bioprostheses on the market.   You can find out more in the #article on our website: https://lnkd.in/dFGQGF2C #BioCompatibilityInnovation #bioprothesis #BCItechnology #tissuetreatment #αGal

BCI is pleased to announce that will be present at #EuroPCR2024, the upcoming world-leading course in #InterventionalCardiology, taking place in Paris from May 14th to 17th, 2024.   At the 'Intervention for valvular disease' #section, you can join Prof. #Isaac George presenting the #ePoster "Polyphenols as a glutaraldehyde substitute for heart valve bioprostheses: validation studies”.   The e-Poster will present the scientific principles of the innovative treatment based on #polyphenols for heart valve bioprostheses, developed by #BiocompatibilityInnovation.   We welcome you to know more about BCI at #EuroPCR! https://lnkd.in/gt8YfqB #biocompatibility #heartvalve #bioprothesis #BCIproject #tissuetreatment

We are pleased to announce that #BiocompatibilityInnovation has been selected for the 2nd #InnovationSummit, organized by the European Association for #CardioThoracic Surgery. The two-day highly interactive working symposium will be held in the Paris area from April 18th to 20th, 2024. Prof. #AndreaColli will participate on behalf of BCI as an invited #speaker for a #talk on 19th April at 16:05 within the 'Heart valve of the future' session about the promising data of #Facta ® as a mitigating agent for the risk associated with the use of glutaraldehyde to manufacture #heart valve bioprostheses. #biocompatibility #bioprothesis #heartvalve #BCIproject #tissuetreatment